Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Geriatric Medicines Market Be Worth By 2029?

The market for geriatric medicines has witnessed swift expansion in the recent past. The market which was valued at $1227.91 billion in 2024, is foreseen to reach $1427.01 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 16.2%. The noteworthy growth during the historical period is ascribed to factors such as the increasing incidence of stroke, rising prevalence of chronic conditions, escalating occurrence of cardiovascular diseases, enhanced government backing, and a growing focus on individualized treatment.

In the coming years, the geriatric medicines market is projected to witness a rapid expansion, growing to a staggering $2578.21 billion in 2029 with a compound annual growth rate (CAGR) of 15.9%. Factors attributed to this growth in the forecast period include an increase in health conditions associated with aging, growth in geriatric populations, an increase in healthcare spending, an upward trend in geriatric medicine, and a surge in hypertension cases. During the forecast period, key trends include the adoption of digital pills and wearable health monitors, the development of safe medication management tools and strategies, progress in stem cell and gene therapy, the broad use of telehealth platforms, and improvements in the early detection and prevention of diseases related to aging.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20817&type=smp

Which Key Factors Are Fueling Growth In The Geriatric Medicines Market?

The upward trend in the incidence of health issues related to aging is anticipated to drive the expansion of the geriatric medicines market. Age-related health conditions, which become more common and severe with age due to the biological process of aging, are primarily fueled by extended life spans, healthcare advancements, and an older population. Geriatric medicines are integral in managing these conditions as they offer targeted treatment for the elderly, enhancing their health outcomes and quality of life. For example, a March 2023 report from the UK government’s Office for Health Improvement and Disparities (OHID) revealed that in 2022, 17.6% of individuals aged 16 and above reported experiencing a long-term musculoskeletal (MSK) condition like arthritis or persistent back or joint problems, up from the 17.0% prevalence in 2021. Consequently, the surging incidence of health problems associated with aging propels the growth of the geriatric medicines market.

Which Segmentation Factors Are Critical In The Geriatric Medicines Market Analysis?

The geriatric medicinesmarket covered in this report is segmented –

1) By Therapeutics: Analgesics; Antihypertensive; Statins; Proton Pump Inhibitors; Anticoagulant; Antipsychotic; Other Therapeutics

2) By Condition: Cardiovascular; Arthritis; Neurological; Cancer; Osteoporosis; Respiratory; Other Conditions

3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

Subsegments:

1) By Analgesics: Non-Opioid Analgesics (Acetaminophen, NSAIDs); Opioid Analgesics (Morphine, Oxycodone); Topical Analgesics (Lidocaine Patches)

2) By Antihypertensive: Angiotensin-Converting Enzyme (ACE) Inhibitors; Angiotensin II Receptor Blockers (ARBs); Beta-Blockers; Calcium Channel Blockers; Diuretics; Alpha-Blockers

3) By Statins: Atorvastatin; Simvastatin; Rosuvastatin; Pravastatin; Lovastatin

4) By Proton Pump Inhibitors: Omeprazole; Esomeprazole; Lansoprazole; Pantoprazole; Rabeprazole

5) By Anticoagulant: Warfarin; Direct Oral Anticoagulants (DOACs): Dabigatran, Rivaroxaban, Apixaban; Heparin

6) By Antipsychotic: Atypical Antipsychotics; Typical Antipsychotics

7) By Other Therapeutics: Antidepressants (SSRIs, SNRIs); Antidiabetic Medications (Insulin, Metformin); Anticonvulsants; Anti-Inflammatory Drugs (Corticosteroids); Cognitive Enhancers (Donepezil, Memantine)

What Are The Dominant Trends Currently Seen In The Geriatric Medicines Market?

Leading businesses in the geriatric medicines market are prioritizing the creation of revolutionary diabetes treatments in order to meet the escalating need for efficient solutions among the elderly population. These cutting-edge diabetes therapies go beyond traditional methods, significantly enhancing the management of diabetes and offering potential cures. They also improve safety, effectiveness and patient results. In August 2023, for example, Akums Drugs & Pharmaceuticals Ltd., a pharmaceutical manufacturing company based in India, unveiled a innovative combination therapy consisting of Vildagliptin SR and Metformin SR. This novel formulation is specifically engineered to deal with Type 2 diabetes management in older patients. Aiming to deliver efficient control of blood sugar, the therapy also tackles major worries such as hypoglycemia and weight gain, especially vital issues for this age group. Both drugs’ mechanisms are synergistically utilized in the combination, promoting insulin secretion and efficiently lowering blood sugar levels, guaranteeing safety and effectiveness. The Drug Controller General of India (DCGI) has granted this product regulatory approval.

Which Players Are Shaping The Competitive Landscape Of The Geriatric Medicines Market?

Major companies operating in the geriatric medicines market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Regeneron Pharmaceuticals Inc., Macleods Pharmaceuticals Ltd., Apotex Inc., Intas Pharmaceuticals Limited, Dr. Reddy’s Laboratories, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Endo Pharmaceuticals Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/geriatric-medicines-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Geriatric Medicines Market?

North America was the largest region in the geriatric medicines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the geriatric medicines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=20817&type=smp

Browse Through More Reports Similar to the Global Geriatric Medicines Market 2025, By The Business Research Company

Autoimmune Disease Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Granulocyte Colony Stimulating Factors Market 2025

https://www.thebusinessresearchcompany.com/report/granulocyte-colony-stimulating-factors-market

Drug Delivery Devices Market 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model